Author:
Ciani Oriana,Wilcher Britni,Blankart Carl Rudolf,Hatz Maximilian,Rupel Valentina Prevolnik,Erker Renata Slabe,Varabyova Yauheniya,Taylor Rod S.
Abstract
Objectives: The aim of this study was to review and compare current health technology assessment (HTA) activities for medical devices across non-European Union HTA agencies.Methods: HTA activities for medical devices were evaluated from three perspectives: organizational structure, processes, and methods. Agencies were primarily selected upon membership of existing HTA networks. The data collection was performed in two stages: stage 1–agency Web-site assessment using a standardized questionnaire, followed by review and validation of the collected data by a representative of the agency; and stage 2–semi-structured telephone interviews with key informants of a sub-sample of agencies.Results: In total, thirty-six HTA agencies across twenty non-EU countries assessing medical devices were included. Twenty-seven of thirty-six (75 percent) agencies were judged at stage 1 to have adopted HTA-specific approaches for medical devices (MD-specific agencies) that were largely organizational or procedural. There appeared to be few differences in the organization, process and methods between MD-specific and non–MD-specific agencies. Although the majority (69 percent) of both categories of agency had specific methods guidance or policy for evidence submission, only one MD-specific agency had developed methodological guidelines specific to medical devices. In stage 2, many MD-specific agencies cited insufficient resources (budget, skilled employees), lack of coordination (between regulator and reimbursement bodies), and the inability to generalize findings from evidence synthesis to be key challenges in the HTA of medical devices.Conclusions: The lack of evidence for differentiation in scientific methods for HTA of devices raises the question of whether HTA needs to develop new methods for medical devices but rather adapt existing methodological approaches. In contrast, organizational and/or procedural adaptation of existing HTA agency frameworks to accommodate medical devices appear relatively commonplace.
Publisher
Cambridge University Press (CUP)
Reference28 articles.
1. Levin L . Medical devices: Are different HTA approaches really needed? The Ontario Experience. HTAi 11th Annual Meeting. Washington DC; 2014. http://www.htai2014.org/temp/201452638552/HTAI_AbstractVolume_web1.pdf (accessed March 4, 2015).
2. Developing and evaluating complex interventions: the new Medical Research Council guidance
3. Bias modelling in evidence synthesis
4. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献